Results 161 to 170 of about 44,432 (315)

RESOLVED [PDF]

AJN, American Journal of Nursing, 1903
ALICE B. HOUGHWOUT, GERTRUDE E. KILPATRICK, SARAH H. STRAIN   +2 more
openaire   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

The $S$-resolvent estimates for the Dirac operator on hyperbolic and spherical spaces [PDF]

Ivan Beschastnyi, Fabrizio Colombo, Simão Lucas, Irene Sabadini   +3 more
openalex   +1 more source

Exponential bounds of the resolvent for a class of noncompactly supported perturbations of the Laplacian [PDF]

, 2000
Georgi Vodev
openalex   +1 more source

Padé-type Approximations to the Resolvent of Fractional Powers of Operators [PDF]

, 2020
Lidia Aceto, Paolo Novati
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Resolvent growth and Birkhoff-regularity [PDF]

, 2005
Arkadi Minkin
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Approximation of Dirac Operators with Confining Electrostatic and Lorentz Scalar δ -Shell Potentials. [PDF]

Complex Anal Oper Theory
Stelzer-Landauer C.
europepmc   +1 more source

On the Spectral Form Factor for Random Matrices. [PDF]

Commun Math Phys, 2023
Cipolloni G, Erdős L, Schröder D.
europepmc   +1 more source